Bulletin
Investor Alert

Olema Pharmaceuticals Inc.

NAS: OLMA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 4:05 p.m.

/zigman2/quotes/222642382/composite

$

2.25

Change

-0.01 -0.44%

Volume

Volume 979

Quotes are delayed by 20 min

/zigman2/quotes/222642382/composite

Previous close

$ 2.30

$ 2.26

Change

-0.04 -1.74%

Day low

Day high

$2.13

$2.38

Open

52 week low

52 week high

$2.00

$32.77

Open

Annual Financials for Olema Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 2018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -8,2449,03311,0001.66M
COGS excluding D&A -----
Depreciation & Amortization Expense -8,2449,03311,0001.66M
Depreciation -8,2449,03311,0001.39M
Amortization of Intangibles ----276,000
Gross Income -(8,244)(9,033)(11,000)(1.66M)
2018201920202021 5-year trend
SG&A Expense -2.07M4.31M21.52M69.83M
Research & Development -1.69M3.92M13.7M51.1M
Other SG&A -377,756393,9677.81M-
Other Operating Expense -----
Unusual Expense -94,000---
EBIT after Unusual Expense -(2.17M)---
Non Operating Income/Expense ----(47,000)
Non-Operating Interest Income -4,0007,00060,000442,000
Equity in Affiliates (Pretax) -----
Interest Expense -28,000-653,000-
Gross Interest Expense -28,000-653,000-
Interest Capitalized -----
Pretax Income -(2.2M)(4.32M)(22.12M)(71.1M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(2.2M)(4.32M)(22.12M)(71.1M)
Minority Interest Expense -----
Net Income -(2.2M)(4.32M)(22.12M)(71.1M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(2.2M)(4.32M)(22.12M)(71.1M)
Preferred Dividends ---1.87M-
Net Income Available to Common -(2.2M)(4.32M)(23.99M)(71.1M)
EPS (Basic) -(0.06)(0.11)(0.61)(1.80)
Basic Shares Outstanding -37.52M40.17M39.31M39.52M
EPS (Diluted) -(0.06)(0.11)(0.61)(1.80)
Diluted Shares Outstanding -37.52M40.17M39.31M39.52M
EBITDA -(2.07M)(4.31M)(21.52M)(69.83M)
Link to MarketWatch's Slice.